five-year follow-up of an organized population of males between 35 and 54 years of age and medication of patients with arterial hypertension ( ah ) demonstrated possibilities of considerably reducing the incidence of cerebral insult ( by 42.9 % ) and myocardial infarction ( by 15.5 % ) and the respective mortality rates ( by 56.1 % and 23.8 % ) , invalidism associated with cardiovascular diseases ( by 36 % ) , temporary disability because of ah ( by 38.2 % ) .
C0027051
myocardial infarction
C0007226
cardiovascular